Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
Cancer Research UK - United Kingdom
PubMed
22659184
DOI
10.1016/j.febslet.2012.05.034
PII: S0014-5793(12)00420-6
Knihovny.cz E-resources
- MeSH
- Models, Biological MeSH
- Gene Deletion MeSH
- HEK293 Cells MeSH
- Immunoprecipitation MeSH
- Nuclear Proteins chemistry physiology MeSH
- Protein Conformation MeSH
- Humans MeSH
- Molecular Sequence Data MeSH
- DNA Mutational Analysis * MeSH
- Tumor Suppressor Protein p53 chemistry metabolism MeSH
- Cell Cycle Proteins MeSH
- Proto-Oncogene Proteins c-mdm2 chemistry genetics physiology MeSH
- Proto-Oncogene Proteins chemistry physiology MeSH
- Amino Acid Sequence MeSH
- Sequence Homology, Amino Acid MeSH
- Protein Structure, Tertiary MeSH
- Ubiquitin chemistry MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Nuclear Proteins MeSH
- MDM2 protein, human MeSH Browser
- MDM4 protein, human MeSH Browser
- Tumor Suppressor Protein p53 MeSH
- Cell Cycle Proteins MeSH
- Proto-Oncogene Proteins c-mdm2 MeSH
- Proto-Oncogene Proteins MeSH
- TP53 protein, human MeSH Browser
- Ubiquitin MeSH
The exact role of the central acidic domain of Mdm2 in p53 degradation remains unclear. We therefore performed a systematic and comprehensive analysis of the acidic domain using a series of short deletions and found that only a minor part of the domain was indispensable for Mdm2-mediated p53 ubiquitylation. Moreover, we identified a short stretch of acidic amino acids required for p53 degradation but not ubiquitylation, indicating that, in addition to p53 ubiquitylation, the acidic domain might be involved in a critical post-ubiquitylation step in p53 degradation. Rather than representing a single functional domain, different parts of the acidic region perform separate functions in p53 degradation, suggesting that it might be possible to therapeutically target them independently.
References provided by Crossref.org